| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfd617dc43a4c986d2dd81e4cb39d9dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e00711e7ad432a363de2b316c40a92e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0812
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-02 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-02 |
| filingDate |
1996-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2001-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f45d9be30c3e80bdf1bebbb86ac353ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65c84210b58fe615f11c7a418f96771f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e779e27c16f7911f4b80208346c64140
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ec46d006453b636e3c414142d4fa0a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71a128d91f5c01f281f03f604d70d907
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24cd331dac95200041d3a85b04f3000f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab0792d6057862709592eef34f4f71ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8ce9b6f93a5d512fc45cd303d3a64a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b65e3ff14c2f4632a515d2939086839c |
| publicationDate |
2001-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6228841-B1 |
| titleOfInvention |
Peptide derivatives |
| abstract |
Compounds represented by the following general formula and salts thereof; Y-L-Tyr-Q-NR1-CH(R2)-CO-X, wherein R1 represents hydrogen or C1-6 alkyl; R2 represents optionally substituted benzyl; Q represents D- or L-Arg; Y represents two hydrogen atoms of N-terminal amino group of L-Tyr, or one or two functional groups substituting for the hydrogen atoms, for example, a C1-6 alkyl optionally having amino or carboxy; and X represents N-methyl-beta-alanine and other. The compounds have analgesic effect and can be used for the treatment of cancer pain or the like. |
| priorityDate |
1995-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |